Scribe Therapeutics, Inc. (SCTX) Form 10-Q Quarterly Reports
Scribe Therapeutics, Inc. (SCTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SCTX
CIK: 1853921
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJonathan Margate
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-09-02 | 2026-06-30 | 10-Q | 0001193125-26-380191 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | 8-K | 0001193125-26-380184 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0001346824-26-000210 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-30 | — | SCHEDULE 13D Filing | 0000902664-26-003281 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-30 | — | SCHEDULE 13D Filing | 0000059478-26-000072 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 Filing | 0001231919-26-000813 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-23 | 4 Filing | 0000947871-26-000734 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 Filing | 0000947871-26-000733 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-07-29 | — | SCHEDULE 13D Filing | 0000947871-26-000732 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 Filing | 0001739090-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | 4 Filing | 0000902664-26-003270 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-03-13 | 4 Filing | 0002147277-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-03-13 | 4 Filing | 0001781292-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-03-13 | 4 Filing | 0002127814-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 Filing | 0001282930-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 Filing | 0002130384-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 Filing | 0002075052-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-03-13 | 4 Filing | 0002127908-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 Filing | 0000902664-26-003254 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | 8-K | 0001193125-26-318263 | View SEC Doc Filr Page |
| S-8 | 2026-07-27 | — | S-8 | 0001193125-26-316529 | View SEC Doc Filr Page |
| 424B4 | 2026-07-27 | — | 424B4 | 0001193125-26-316503 | View SEC Doc Filr Page |
| FWP | 2026-07-24 | — | FWP | 0001193125-26-314757 | View SEC Doc Filr Page |
| EFFECT | 2026-07-23 | — | EFFECT Filing | 9999999995-26-002417 | View SEC Doc Filr Page |
| 3 | 2026-07-23 | 2026-07-23 | 3 | 0001193125-26-314787 | View SEC Doc Filr Page |